Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantDCH AURIGA SINGAPORE
Licence HolderDCH AURIGA SINGAPORE
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
SOLUTION
**Dosage:** One drop to be instilled into the eye twice daily. Treatment should be continued for at least two days after the eye appears normal.
OPHTHALMIC
Medical Information
**Indications:** Bacterial eye infections caused by susceptible organisms in conjunctivitis, blepharitis, sty, keratitis, dacryocystitis and in connection with removal of foreign bodies.
**Contra-indications:** Hypersensitivity to any component.
S01AA13
fusidic acid
Manufacturer Information
DCH AURIGA SINGAPORE
LEO PHARMACEUTICAL PRODUCTS LTD. A/S
LEO LABORATORIES LIMITED
Active Ingredients
Documents
Package Inserts
Fucithalmic Eye Drops 1% PI.pdf
Approved: July 13, 2015